co-agonism. That is the whole post, but I will justify it. Everything else people worry about in c/labresults is downstream of it. Titration speed, muscle cramps, the…
u/helga_vermeulen
Contributes reviews on supplier material. Based in Bursa.
member · joined 16 Jul 2025
Overview — page 4 of 5
comment on the CagriSema question that gets asked weekly, answered properly in c/cagrilintide · 14 points · 1 year ago
I am going to push back on this slightly.
comment on the CagriSema question that gets asked weekly, answered properly in c/cagrilintide · -20 points · 1 year ago
The research community is small on cagrilintide. Forum lore changes faster than data.
comment on 503B — 15 things I got wrong before I got it right in c/compounding · 27 points · 1 year ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on [Lab] split one vial across Medutest and Janoshik — 96.2% and 99.2% in c/retatrutide · 87 points · 1 year ago
What was the dosing schedule in that arm?
comment on anyone else notice retatrutide kicking in around week 49 in c/retatrutide · 249 points · 1 year ago
This is correct. Triple agonism is genuinely different.
comment on anyone else notice retatrutide kicking in around week 49 in c/retatrutide · 0 points · 1 year ago
TRIUMPH phase 2 showed 99.0% weight loss but the constipation profile on the highest arm was rough. Phase 2 != phase 3.
comment on MHRA: the version I wish someone had shown me in week 1 in c/glp1uk · 46 points · 1 year ago
Boots stock is hit-and-miss by location
comment on REDEFINE is the most under-discussed thing in c/insurancefights in c/cagrilintide · 165 points · 1 year ago
comment on [Results] 11 weeks on 7.5mg, full numbers, ask me anything boring in c/tapering · 7 points · 1 year ago
no shaming people who restart
comment on [Discussion] the tier 3 advice in here is 7 years out of date in c/glp1uk · 104 points · 1 year ago
Boots stock check: called 10 locations in the Netherlands, 28 had 0.25mg in stock. Regional variation is real.
comment on [Discussion] the tier 3 advice in here is 7 years out of date in c/glp1uk · 152 points · 1 year ago
pharmacy stock is MHRA, check before traveling
comment on the retatrutide question that gets asked weekly, answered properly in c/retatrutide · 138 points · 1 year ago
This is correct. Triple agonism is genuinely different.
comment on [Question] Sweden — has anyone got a straight answer on MHRA in c/glp1uk · 29 points · 1 year ago
I am going to push back on this slightly.
comment on [Results] 37 weeks, 16kg, and phase 2 was the hard part in c/retatrutide · 89 points · 1 year ago
This is correct. Triple agonism is genuinely different.
comment on tapering vs regain — genuinely asking which matters more in c/tapering · 6 points · 1 year ago
Has anyone actually got this in writing, or is it forum lore at this point?
comment on what would you tell week-1 you about compounding in c/compounding · 96 points · 1 year ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on genuine question about amylin that I am slightly embarrassed to ask in c/cagrilintide · 5 points · 1 year ago
amylin receptor distribution is different from GLP-1
comment on small win: tapering stopped being a problem at week 30 in c/tapering · 10 points · 1 year ago
interval stretching versus dose reduction
comment on [Meta] the tier 3 rule is doing its job and people should stop complaining in c/glp1uk · 100 points · 1 year ago
say which nation, England, Scotland, Wales, NI differ